|
Drug Delivery Systems
|
D016503 |
[Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.
] |
|
Bcl-2-Like Protein 11
|
D12.644.360.075.323 |
|
|
Color Therapy
|
D016500 |
[A form of phototherapy using color to influence health and to treat various physical or mental disorders. The color rays may be in the visible or invisible spectrum and can be administered through colored lights or applied mentally through suggestion.
] |
|
Neurites
|
D016501 |
[In tissue culture, hairlike projections of neurons stimulated by growth factors and other molecules. These projections may go on to form a branched tree of dendrites or a single axon or they may be reabsorbed at a later stage of development. "Neurite" may refer to any filamentous or pointed outgrowth of an embryonal or tissue-culture neural cell.
] |
|
Neuroepithelial Cells
|
A08.800.950.500.530 |
|
|
Fracture Dislocation
|
C26.289.336 |
|
|
Percutaneous Coronary Intervention
|
E04.502.382.968 |
|
|
2-Hydroxy-5-nitrobenzyl Bromide
|
D02.455.426.559.389.657.566.400 |
|
|
Osteoarthritis, Hip
|
C05.799.613.400 |
|
|
Nephroma, Mesoblastic
|
C13.351.937.820.535.790 |
|
|
Descemet Membrane
|
A09.371.060.217.271 |
|
|
Neurofibromatosis 2
|
D016518 |
[An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
] |
|
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
|
D13.570.685.245.500.600.500 |
|
|
Genes, Neurofibromatosis 2
|
D016515 |
[Tumor suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes NEUROFIBROMATOSIS 2.
] |
|
Reality Testing
|
F02.739.794.206.508 |
|
|
CD4-CD8 Ratio
|
D016516 |
[Ratio of T-LYMPHOCYTES that express the CD4 ANTIGEN to those that express the CD8 ANTIGEN. This value is commonly assessed in the diagnosis and staging of diseases affecting the IMMUNE SYSTEM including HIV INFECTIONS.
] |
|
Hospitals, Religious
|
D016519 |
[Private hospitals that are owned or sponsored by religious organizations.
] |
|
Entamoeba histolytica
|
B01.046.500.100.700.335.330 |
|
|
Tympanocentesis
|
E04.665.600.905 |
|
|
Corneal Neovascularization
|
D016510 |
[New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
] |
